READ-ONLY DIGITIZATION RESULT
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
J Immunother Cancer · 2024-Oct-24 · PMID 39455094
Panel B质量警告待 EXE 对齐验证
Progression-free survival
Figure 3. Kaplan-Meier curves of the BIRC-assessed efficacy outcomes for GCB patients in the Hi-CHOP and R-CHOP groups (FAS). ( A ) Duration of response, ( B ) progression-free survival, ( C ) events-free survival and ( D ) overall survival note. The cut-off date for the analysis was August 31, 2022, with a median follow-up period of 29.6 months. BIRC, blinded independent review committee; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone; FAS, full analysis set; GCB, germinal center B‐cell‐like; Hi-CHOP, zuberitamab plus CHOP; NE, not evaluable; R-CHOP, rituximab plus CHOP.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
| Curve | 序号 | X (norm) | Y (norm) | X (real) | Y (real) | X (pixel) | Y (pixel) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0.0000 | 1.0000 | 0.0000 | 0.9764 | 37 | 0 |
| 1 | 2 | 0.1373 | 1.0000 | 5.3552 | 0.9764 | 83 | 0 |
| 1 | 3 | 0.1403 | 1.0000 | 5.4716 | 0.9764 | 84 | 0 |
| 1 | 4 | 0.1433 | 1.0000 | 5.5881 | 0.9764 | 85 | 0 |
| 1 | 5 | 0.1463 | 1.0000 | 5.7045 | 0.9764 | 86 | 0 |
| 1 | 6 | 0.1493 | 1.0000 | 5.8209 | 0.9764 | 87 | 0 |
| 1 | 7 | 0.1522 | 1.0000 | 5.9373 | 0.9764 | 88 | 0 |
| 1 | 8 | 0.1552 | 1.0000 | 6.0537 | 0.9764 | 89 | 0 |
| 1 | 9 | 0.1582 | 1.0000 | 6.1701 | 0.9764 | 90 | 0 |
| 1 | 10 | 0.1612 | 1.0000 | 6.2866 | 0.9764 | 91 | 0 |
| 1 | 11 | 0.1642 | 1.0000 | 6.4030 | 0.9764 | 92 | 0 |
| 1 | 12 | 0.1672 | 1.0000 | 6.5194 | 0.9764 | 93 | 0 |
| 1 | 13 | 0.1701 | 1.0000 | 6.6358 | 0.9764 | 94 | 0 |
| 1 | 14 | 0.1731 | 1.0000 | 6.7522 | 0.9764 | 95 | 0 |
| 1 | 15 | 0.1761 | 1.0000 | 6.8687 | 0.9764 | 96 | 0 |
| 1 | 16 | 0.1791 | 1.0000 | 6.9851 | 0.9764 | 97 | 0 |
| 1 | 17 | 0.1821 | 0.9891 | 7.1015 | 0.9658 | 98 | 2 |
| 1 | 18 | 0.1851 | 0.9891 | 7.2179 | 0.9658 | 99 | 2 |
| 1 | 19 | 0.1881 | 0.9891 | 7.3343 | 0.9658 | 100 | 2 |
| 1 | 20 | 0.1910 | 0.9891 | 7.4507 | 0.9658 | 101 | 2 |
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:44:02+00:00 |